Introduction: new developments in the treatment of attention-deficit/hyperactivity disorder.


Guanfacine Guanfacine, an α2-adrenergic receptor agonist, has had mixed results in the treatment of ADHD. Although guanfacine has been shown to have cognitive-enhancing properties, in a recent study of its effect on executive function and memory, 60 healthy males were randomly assigned guanfacine in double-blind fashion at a single dose of 1 mg, 2 mg, or… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics